Ruijuan Luo

Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-Chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development

Angelo Aguilar, Jianfeng Lü, Liu Liu et al. · Journal of Medicinal Chemistry · 2017 · 193 citations · Full text

Distinct biodistribution of doxorubicin and the altered dispositions mediated by different liposomal formulations

Ruijuan Luo, Yan Li, Miao He et al. · International Journal of Pharmaceutics · 2017 · 64 citations

Lipid Preparation, Pharmaceutical Science, Different Liposomal Formulations +4

Measurement of <i>in vivo</i> Gastrointestinal Release and Dissolution of Three Locally Acting Mesalamine Formulations in Regions of the Human Gastrointestinal Tract

Alex Yu, Jason Baker, Ann Fioritto et al. · Molecular Pharmaceutics · 2016 · 52 citations

Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial

Patrick E. Georgoff, Vahagn C. Nikolian, Tess Bonham et al. · Clinical Pharmacokinetics · 2017 · 51 citations · Full text

Drug Safety, Healthy Subjects, Medicine +8

Transformable Capillary Electrophoresis for Oligosaccharide Separations Using Phospholipid Additives

Ruijuan Luo, Stephanie Archer‐Hartmann, Lisa Holland · Analytical Chemistry · 2010 · 41 citations